Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DRY EYE SYNDROME AND DRY EYE SYNDROME-RELATED OPHTHALMOLOGIC DISEASE
Document Type and Number:
WIPO Patent Application WO/2022/235021
Kind Code:
A1
Abstract:
The present invention relates to a composition for prevention, alleviation, or treatment of dry eye syndrome or dry eye syndrome-related ophthalmologic diseases. In the present invention, the protein kinase A (PKA) cell signaling system is activated to effectively reverse the lipid synthesis decrease that may be caused by meibomian gland dysfunction, whereby the lipids secreted from the meibomian gland decrease moisture evaporation from the ocular surface and thus can prevent, alleviate, or treat dry eye syndrome or dry eye syndrome-related ophthalmologic diseases.

Inventors:
JUN IKHYUN (KR)
KIM TAE-IM (KR)
KIM BO-RAHM (KR)
Application Number:
PCT/KR2022/006183
Publication Date:
November 10, 2022
Filing Date:
April 29, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV YONSEI IACF (KR)
International Classes:
A23L33/10; A61K31/353; A61K9/00; A61P27/02
Foreign References:
US20050284812A12005-12-29
KR20090104803A2009-10-06
US6346273B12002-02-12
US5017368A1991-05-21
Other References:
NEBBIOSO M, RUSCIANO D, PUCCI B, ZICARI A M, GRENGA R, PESCOCOLIDO N: "Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial.", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, VERDUCI EDITORE, IT, vol. 17, no. 8, 1 January 2013 (2013-01-01), IT , pages 1117 - 1122, XP093000391, ISSN: 1128-3602
Attorney, Agent or Firm:
PADO IP LAW PLLC (KR)
Download PDF: